Your session is about to expire
← Back to Search
Neurostimulation
Spinal Cord Stimulation for Chronic Pain
N/A
Recruiting
Led By Scott Lempka, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Chronic intractable pain of the trunk and/or limbs
Candidates who are 18 years or older and can speak, read, and understand English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (at randomization) and at the end of each seven-day treatment
Awards & highlights
Study Summary
This trial will study how well different types of electrical spinal cord stimulation work to relieve pain in people who already have it as part of their standard care.
Who is the study for?
This trial is for adults with chronic pain in the trunk or limbs who are already using spinal cord stimulation (SCS) as part of their treatment. Participants must be over 18, speak English, and follow study procedures. They should agree to COVID-19 precautions and not have used nail enhancements recently. Pregnant women and those with recent or current COVID-19 are excluded.Check my eligibility
What is being tested?
The study is testing how different forms of SCS affect pain relief in patients with conditions like Complex Regional Pain Syndrome and neuropathic pain. It involves regular evaluations to understand the impact of SCS on chronic pain management.See study design
What are the potential side effects?
While specific side effects aren't listed here, SCS can sometimes cause discomfort at the implant site, unwanted changes in nerve activity, infection risk from surgery, or equipment malfunction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have ongoing severe pain in my trunk or limbs.
Select...
I am 18 or older and can speak, read, and understand English.
Select...
I am receiving spinal cord stimulation for chronic pain management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (at randomization) and at the end of each seven-day treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at randomization) and at the end of each seven-day treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
SCS-induced changes in temporal summation (TS)
Trial Design
6Treatment groups
Experimental Treatment
Group I: kHz / Sham / Burst / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Group II: kHz / Burst / Sham / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Group III: Sham / kHz / Burst / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Group IV: Sham / Burst / kHz / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Group V: Burst / kHz / Sham / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Group VI: Burst / Sham / kHz / TonicExperimental Treatment1 Intervention
Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal cord stimulation
2022
N/A
~30
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,891 Total Patients Enrolled
31 Trials studying Chronic Pain
3,781 Patients Enrolled for Chronic Pain
National Center for Complementary and Integrative Health (NCCIH)NIH
831 Previous Clinical Trials
668,908 Total Patients Enrolled
45 Trials studying Chronic Pain
17,953 Patients Enrolled for Chronic Pain
Scott Lempka, PhDPrincipal Investigator - University of Michigan
University of Michigan
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Chronic Pain
20 Patients Enrolled for Chronic Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have ongoing severe pain in my trunk or limbs.I have tested positive for COVID-19 or shown symptoms in the last 14 days.I understand and can follow the study's procedures for its duration.I am 18 or older and can speak, read, and understand English.You have already had a commercial SCS device implanted.I have no conditions that would stop me from completing the study.I am receiving spinal cord stimulation for chronic pain management.
Research Study Groups:
This trial has the following groups:- Group 1: kHz / Sham / Burst / Tonic
- Group 2: Burst / kHz / Sham / Tonic
- Group 3: Sham / kHz / Burst / Tonic
- Group 4: Burst / Sham / kHz / Tonic
- Group 5: kHz / Burst / Sham / Tonic
- Group 6: Sham / Burst / kHz / Tonic
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the upper bound of participants in this experiment?
"Affirmative. Clinicaltrials.gov exhibits evidence that this trial, originally posted on the 11th of September 2021, is still in need of volunteers. A single location requires 25 participants to complete its experiment."
Answered by AI
Does this clinical experiment still have vacancies for participants?
"Affirmative. According to clinicaltrials.gov, this experiment is presently recruiting volunteers; it was initially posted on September 11th 2021 and has been modified most recently on October 5th 2022. Approximately 25 patients need to be enrolled from 1 trial centre ."
Answered by AI
Who else is applying?
What state do they live in?
Michigan
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger